NCT05591521Completed
Evaluation of Pain in the Course of in Vitro Fertilization: the Endalgofiv-2 Study
Source: ClinicalTrials.gov · Last updated 26 Dec 2025
Brief summary (registry, in English)
The ENDALGOFIV study of pain assessment during the IVF pathway at Lille University Hospital, conducted from November 2018 to July 2020, showed that endometriosis patients have intense pain, particularly of a neuropathic nature, even before starting their IVF pathway compared to patients without endometriosis, but without an increase in pain scores during the IVF pathway. As a result of this study, a new pain management protocol for all patients undergoing IVF have been implemented in our MPA center. The study will be evaluated the impact of this new management. Main objective To evaluate the effect of the change in pain management protocol in all patients (endometriotic or not) undergoing IVF treatment during the study period by comparing them to the data of the ENDALGOFIV 1 study.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 206 (actual)
- First submitted
- 11 Aug 2022
- Start date
- 30 Nov 2022
- Primary completion date
- 24 Mar 2024
- Lead sponsor
- University Hospital, Lille
- Diseases
- Endometriosis
- NCT number
- NCT05591521
What you commit to
- Study type: Observational
- Participants enrolled: 206
- From 30 Nov 2022 to the primary completion date, 24 Mar 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previously enrolled patient (ENDALGOFIV or ENDALGOFIV 2)
Age
- Patient over 43 years old
Other
- Refusal to participate in the study
- Minor patient
- BMI patient \> 35
- Pregnant woman
- Unable to provide clear information to the patient
- Patient under guardianship or lack of health cover
- Patient in IVF with donation of oocyte
- IVF patients for oocyte preservation
- Patient who had already participated in the study
Who the study is looking for
- All patients who start an IVF cycle in the medically assisted procreation department of the Jeanne de Flandres Hospital (CHRU Lille)
Age in the registry: 18 years to 43 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hop Jeanne de Flandre Chu Lille Coordinator of this site? Confirm its status | Lille | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.